SBL
ELI

Sargent Bickham Lagudis’s ELITE PHARMACEUTICAL ELI Stock Holding History

Sargent Bickham Lagudis’s Portfolio ELI Stock Details ELI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-40,000
Closed -$4K – 871
2017
Q3 		$4K Hold
40,000
– – ﹤0.01% 722
2017
Q2 		$8K Hold
40,000
– – ﹤0.01% 617
2017
Q1 		$6K Hold
40,000
– – ﹤0.01% 653
2016
Q4 		$6K Hold
40,000
– – ﹤0.01% 620
2016
Q3 		$7K Hold
40,000
– – ﹤0.01% 623
2016
Q2 		$13K Hold
40,000
– – ﹤0.01% 517
2016
Q1 		$12K Buy
+40,000
New +$12K ﹤0.01% 550

Other funds holding ELI

JAFL
Jay A. Fishman Ltd Troy, Michigan $1.26B AUM 31.39% 1-Year Est. Return

Sargent Bickham Lagudis's ELI Position: Q4 2017 in Review

Sargent Bickham Lagudis sold out of ELITE PHARMACEUTICAL (ELI) in Q4 2017, closing a stake of 40,000 shares — an estimated $4K sold.

Sargent Bickham Lagudis first reported a position in ELI in Q1 2016 and held it in 7 quarters. The position peaked at $13K in Q2 2016. 1 fund tracked by Wall St. Rank holds ELI as of Q4 2017.

  • Sargent Bickham Lagudis reported no remaining ELITE PHARMACEUTICAL position as of Q4 2017 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 40,000 ELITE PHARMACEUTICAL shares in Q4 2017, an estimated $4K.
  • Sargent Bickham Lagudis first reported a position in ELITE PHARMACEUTICAL in Q1 2016 and held it in 7 quarters.
  • Sargent Bickham Lagudis's ELITE PHARMACEUTICAL position peaked at $13K in Q2 2016.
  • 1 fund tracked by Wall St. Rank held ELITE PHARMACEUTICAL as of Q4 2017.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2017, filed 13 Sep 2021.